Summary The effect of adriamycin (ADM) infusion-rate on cellular ADM concentrations and on clonogenicity of human haematopoietic cells was studied in vivo and in vitro. In patients an ADM dose of 30mgm-2 was administered as a bolus injection, or as a 4 h or a 24 h infusion. In vitro the effect of ADM on clonogenic cell growth was determined after exposure during 5 min, 2 h and 24 h of human bone marrow cells to increasing ADM concentrations. ADM showed rapid intracellular accumulation, to levels 100-fold the plasma concentration in vivo or the incubation medium concentration in the in vitro experiments. After a bolus injection or 5 min exposure only 10% of the cellular peak ADM was retained after elimination of the drug from the plasma or the incubation medium. Ninety percent of the ADM was apparently 'loosely' bound. After 4 h and 24 h constant-rate infusions and also after 2 h and 24 h incubations in vitro, the cells accumulated ADM gradually, and the subsequent washing-out of the cellular ADM was substantially less, most of the ADM being 'tightly' bound. Despite these different patterns of uptake and retention after in vivo short-and long-lasting infusion of the same total dose, the 'tightly-bound' cellular ADM concentrations were the same. Moreover, comparable cellular ADM concentrations, retained after efflux of the 'loosely-bound' cellular ADM fraction were equally cytotoxic to normal human clonogenic cells. Short-lasting cellular peak ADM concentrations which occur after a bolus injection or after short exposure to high ADM concentrations are not essential for the cytotoxic effect, in contrast to the retained, 'tightly-bound' cellular ADM levels.
Adriamycin (ADM), usually given as a bolus injection, has also been administered as a constant rate infusion for several hours or days. Prolonged administration of anthracyclines has the advantage of avoiding high peak plasma concentrations (Legha et al., 1982; Speth et al., 1986 ) thus reducing side-effects such as nausea, vomiting and cardiotoxicity (Legha et al., 1982) . Given as bolus injections the cumulative ADM dose is limited to 550mg m -2, but this dose can be safely exceeded if ADM is infused (Legha et al., 1982; Benjamin et al., 1985) . Therapeutic efficacy of continuous infusions appeared not different from that of bolus injections, as was observed in leukaemia (Lewis et al., 1985) and in breast cancer treatment (Garnick et al., 1982) .
No data are available regarding either the cellular ADM levels or the cytotoxicity to clonogenic cells following the different modes of administration. In this study plasma and cellular ADM concentrations were monitored in plasma, blood cells and bone marrow cells and bone marrow samples were assayed for clonogenicity. In vivo studies were supplemented by in vitro experiments, in which the cellular ADM levels were measured after different exposure times to various ADM concentrations. This approach offered the possibility to study the effects of both short-lasting cellular peak concentrations and long-lasting lower cellular drug concentrations on clonogenicity. (Speth et al., 1985) .
Materials and methods

Drugs
In vivo measurement of clonogenicity In 2 patients (leukaemia in remission) clonogenicity was determined before and 1 h after a push injection, given as part of the maintenance treatment. In a third patient, suffering from chronic granulocytic leukaemia, clonogenicity was determined in blast cells taken from the peripheral blood before and after a 4 h infusion of increasing ADM dosages of 40 to 80 mg m-2 on 6 consecutive occasions. Granulocyte-macrophage colony forming cells (CFU-GM) assay
All cultures were performed in duplicate in 35 mm Petri dishes (Costar, Cambridge, Mass, USA) as described previously (De Witte et al., 1982) . In brief, each dish contained 2ml of a cell suspension (105cells ml-) in DMEM supplemented with 20% FCS, 5% (v/v) colony stimulating activity from human placental conditioned medium as described by Verma et al. (1980) (Speth et al., 1985) . From each sample at least 12 x 103 cells were analysed at a flow rate of 1,000 cells sec-1.
FLS, PLS and fluorescence per blast cell (FU/cell) were measured in area mode, stored in list mode and analysed on a PDP 11/34 computer (Digital Electronic Company, Maynard, MA, USA). Blast cell ADM concentrations were expressed in arbitrary FU/cell representing the mean fluorescence of this cell subpopulation. All fluorescence data presented are corrected for autofluorescence by subtracting the blank value. As described previously, the arbitrary fluorescence units correlated well with cellular ADM concentrations determined by HPLC (r = 0.99, n = 9); 100 FU/cell appeared to correspond with -4 to 5 fg/cell, assuming the volume of 109 cells to be 1 ml (Speth et al., 1985) .
Measurement ofplasma and cellular ADM by HPLC The straight-phase HPLC method used was described previously (Speth et al., 1986) . In brief, 3 ml chloroform/methanol 9: 1 (v/v) was added to 250 p1 sonicated cell suspension or 500 p1 plasma, followed by 100 pl Tris buffer (I M, pH 8.8) containing daunomycin as internal standard. After two extractions with chloroform/methanol 9: 1 (v/v), the chloroform phase was evaporated. The residue was dissolved in 750pl chloroform/methanol, with addition of 50 ul Tris buffer. A 500 M1 sample was injected onto the column (Lichrosorb 7Si60 column 100 x 3.0mm I.D.). Detection was carried out with a fluorometer (i-excitation at 488 nm, A-emission above 550 nm) (FS 970 L.S. Fluorometer, Schoeffel Instr, Ramsey, NJ, USA). The detection limit of ADM and adriamycinol was 1 ng. The within-day precision of the method (n= 17) was 7.0%.
Curve fitting of ADM concentration-response curves The ADM concentration-response curves were fitted according to a model described by the formula:
This function contains three dimensions: (a) represents the maximal plating efficiency (= 100%), (b) represents the concentration at which inhibition amounted to 70%, (c) represents the slope of the downward leg of the curve. The model was fitted according to the Gauss-Newton regression procedure with the use of least square criteria (Murray, 1972) .
Results
In vivo plasma and cellular ADM concentrations
The cellular and plasma ADM and plasma adriamycinol concentrations after bolus injection or 4 h or 24 h infusions are illustrated in Figure 1 . Peripheral blood cell ADM concentrations appeared to correlate well with the simultaneously investigated bone marrow ADM concentrations (n=47, r=0.82). After a bolus injection of ADM (30 mg m -2) peak plasma ADM concentrations of 2405+1720 ngml-l (n=9, mean +s.d.) were noted. The plasma disappearance curve of ADM showed a biphasic pattern with a rapid first half-life of -4 min, followed by a terminal half-life of -40 h. Cellular accumulation of ADM followed the plasma levels almost simultaneously and reached peak concentrations of 5740+2100ngml-1 cells (Figure 1 ). The cellular ADM disappearance curves were also biphasic. A short-lasting rapid phase (half-life of 1I0min) was followed by a phase with a slow disappearance rate with a half-life of -100h. The difference between plasma and cellular ADM half-lives resulted in cellular ADM concentrations that were 3 orders of magnitude higher than the plasma concentrations at 24 to 48 h after administration. When the same dose of ADM was administered as a 4 h constant-rate infusion, maximal plasma concentrations were -60-80 ng ml -1. The cellular concentrations showed peak levels of 1100-1200ngml-1. In case of a 4h infusion the 7 E ADM efflux from the cells at the end of the infusion was much less extended compared with bolus injection. In the second, slow ADM disappearance phase, the cellular and plasma ADM curves had similar half-lives to those observed in the case of bolus injection. Constant-rate infusion of 24h resulted in even lower maximal plasma levels (20ngml-1) and a slow but continuous increase of cellular ADM concentrations during the infusion period. At the end of the infusion hardly any loss of cellular ADM was observed.
In all three modes of drug administration 1 h after the plasma ADM concentrations had reached negligible values, (<I0 ng ml-1) almost identical cellular drug concentrations were attained (Figure 1 ).
In vitro cellular ADM concentrations Human bone marrow cells were exposed to a range of ADM concentrations for 5 min, 2 h and 24 h. Cellular ADM uptake and release were measured during ADM exposure and subsequent reincubation in drug-free medium (n = 5). Figure  2 shows an example of the cellular ADM levels after 5 min, 2 h and 24 h exposure to ADM concentrations of 5000, 400 and 40 ng ml-1 respectively. The incubation concentrations in this example were chosen to result in similar growthinhibition of clonogenic cells (80%). It is seen that the plateau concentrations (cellular ADM concentration at reincubation) were comparable. Furthermore the time courses of cellular ADM concentration were essentially the same as observed after in vivo bolus injection and short-or long-term infusion respectively (Figure 1) . A rapidly attained and high cellular ADM concentration after the short-lasting exposure, was followed by a considerable loss (87-91 %) during the two wash steps. During the 2 h and 24 h exposure a more gradual increase of cellular ADM concentrations was followed by a less pronounced loss after the wash steps (27-51% and 12-23% respectively, range of 5 experiments). clonogenicity at the end of the infusion decreased from 51% (40 mg m 2) to 30% (80 mg m -2) of the pre-infusion values. The in vitro concentration-response curves for all 3 exposure times are plotted in Figure 3 (n = 5). The concentration at which 50% inhibition of clonogenic cells occurred (IC50) was calculated from the fitted curves. After 5min exposure the IC50 was 2.2 jigml-1 ADM. Prolonged exposure resulted in cytotoxicity at lower ADM medium concentrations, the IC50 being 0.35 and 0.05pgml-' after 2 h and 24 h respectively. An even lower IC50 of 0.0056 ig ml-1 was achieved after continuous exposure during 12 days culturing when ADM had been added to the semi-solid culture medium. Figure 4 shows the inhibition of clonogenicity as a function of the cellular ADM concentrations, measured at the moment of plating the cells in semi-solid medium. For each point the s.d. ranged between 5 and 25%. The fitted concentration-response curves did not show significant differences.
Discussion
The first part of the in vivo cellular ADM concentration-time curves observed after administration of 30 mg m2 ADM as bolus injection, short-lasting and long-lasting infusions Cellular ADM concentrations and clonogenicity (CFU-GM) In 2 patients clonogenicity was determined before and 1 h after ADM 30 mg m 2 push injection. Clonogenicity was depressed from 100% (before) to 79 and 44% after ADM. In 1 patient clonogenicity was determined on 6 consecutive occasions before and after a 4 h infusion of ADM in increasing dosages of 40 to 80mg m 2. Inhibition of appeared essentially different; after bolus injection high peak concentrations were observed, in contrast to long-lasting infusions, showing a gradual increase of cellular ADM. However, the second part of the concentration-time curves, from the moment the plasma concentrations became negligible, the cellular ADM concentrations reached comparable levels and showed similar disappearance rates. The cellular ADM disappearance curves observed in vitro after 5 min, 2 h and 24 h exposure showed similar patterns as observed in vivo after a bolus injection, a short-and longlasting infusion respectively. The shorter the ADM-infusion or the ADM-exposure time in vitro the more ADM was accumulated intracellularly in the initial phase, but also more of the initially accumulated ADM was subsequently lost. The net result was comparable ADM concentrations if the same total dose was used (in vivo), called 'tightly bound' ADM in contrast to the 'loosely-bound' ADM lost after disappearance of plasma ADM. In vitro the 'tightly-bound' ADM concentrations correlated well with the level of inhibition of clonogenic cells. Loss of cellular ADM after reincubation in drug free medium has been described previously (Preisler & Raza, 1984) . Although the mechanism behind this observation is speculative, it may be explained by a two compartment model with a fast but reversible cytoplasmic accumulation followed by an irreversible intercalation into DNA at a slower rate (Skovsgaard, 1978) .
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